Additionally, synovial sarcoma is characterized by a decreased level of SMARCB1 protein and high expression of SMARCB1 mRNA, which point to a post-transcriptional involvement in SMARCB1 degradation [36]. This evidence concerns the gene SMARCB1 and synovial sarcoma.